Lung Cancer Patients and Parent-child Interaction Experience and Process

Type of study: The goal of this observational study is to explore the relationship between patients with advanced lung cancer and their parent-child interactions during the treatment process, and to understand the impact of the degree of self-differentiation of parents with advanced lung cancer on the physical and mental health of their children. The main questions it aims to answer are:

1. To explore the post-illness adjustment process of patients with advanced lung cancer and the changes in the parent-child relationship among adolescents.
2. To explore the changes in demographic factors-self-belief, mental health, and self-efficacy among patients with advanced lung cancer-and the parent-child relationship among adolescents.
3. Explore the family resilience of patients with advanced lung cancer - family peer relationships, and the interaction between parent-child relationships among adolescents.

Study Overview

• Status: Terminated
• Conditions: Lung Cancer Patients; Parent-child Interaction
• Intervention / Treatment: Other: structured questionnaire

Detailed Description

This study explores the relationship between late-stage lung cancer patients and their parent-child interactions during the treatment process, and understands the impact of the degree of self-differentiation of parents with late-stage lung cancer on their children's physical and mental health.

• Study Type: Observational
• Enrollment (Actual): 109

Contacts and Locations

Study Locations

• Taiwan
  • Taipei, Taiwan, 100225
    • Nation Taiwan University Hospital
  • Taipei City, Taiwan, 100225
    • National Taiwan University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Probability Sample

Study Population

Patients with advanced lung cancer aged 40 to 64 years, and have aged 10 to 19 years old teenagers.

Description

Inclusion Criteria:

1. Patients with advanced lung cancer aged 40 to 64 years (mid-adulthood).
2. There are lung cancer patients in the family who are teenagers aged 10 to 19 years old.
3. Those who voluntarily participate in this study.
4. Voluntary participants can express themselves orally and in handwriting.

Exclusion Criteria:

1. Single lung cancer patients over 65 years old.
2. Lung cancer patients under 40 years old.
3. Patients diagnosed with early-stage lung cancer.
4. Those who have cognitive impairment and are unable to understand the problem.
5. Those who are unable to express and respond to questions.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Parent-child interaction	The interaction between patients with advanced lung cancer and their parents and children during the treatment process	one years
Center for Epidemiological Studies Depression Scale	The CES-D scale is designed to measure an individual's depression level, covering multiple aspects such as depressed mood, guilt, helplessness, decreased appetite, sleep disturbance and psychomotor retardation, with a total of 20 items. The subjects evaluated the frequency of each symptom in the past week using a four-point scale (1 point: never or rarely; 4 points: often). Studies have shown that CES-D has good internal consistency (α=0.85) (Conerly et al., 2002; Given et al., 2004) and reliability (Cronbach's alpha > 0.85) in cancer patients (Hann et al., 2004). al., 1999) , and therefore can effectively assess the level of depression in cancer patients. In short, the CES-D is a validated tool for assessing depression in cancer patients.	one years

Collaborators and Investigators

• Sponsor: National Taiwan University Hospital

Study record dates

Study Major Dates

• Study Start (Actual): December 17, 2023
• Primary Completion (Actual): January 21, 2025
• Study Completion (Actual): January 21, 2025

Study Registration Dates

• First Submitted: June 24, 2024
• First Submitted That Met QC Criteria: February 6, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: February 6, 2025
• Last Verified: August 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Neoplasms by Site; Neoplasms; Respiratory Tract Diseases; Lung Diseases; Respiratory Tract Neoplasms; Thoracic Neoplasms; Lung Neoplasms
• Other Study ID Numbers: 202306102RINB

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No